1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Toll-free: 800.544.0155
All Contents © 2018The Kiplinger Washington Editors
Check out our weekly earnings calendar and read the latest quarterly earnings previews.
Most people may not know it, but only a handful out of every thousand drugs that begin development ever make it to the final stages of trials – and not all of those are approved.
The way we categorize stocks and how they perform is changing. Investors must change along with it. Here's how.
More Investing News »